Jessica Herzig/LinkedIn
Dec 21, 2025, 13:54
Jessica Herzig on CD86 Expression Correlation with Immune Cell Activation
RPTH Journal shared on LinkedIn:
”Why do some hemophilia A patients develop inhibitors?
This study points to immune activation patterns that depend more on timing, even seasonality, than on the FVIII product itself.
Check out this fascinating study by Jessica Herzig and team here.”
Article: Season-dependent low basal CD86 expression promotes immune cell activation upon treatment with plasma-derived factor Ⅷ products
Authors: Jessica Herzig, Josselyn Azucena Arciniega Martinez, Svenja M. Küster, Eva Ringler, Stefanie Kronhart, Gerrit J. K. Praefcke, Lilija Miller, Martina Anzaghe, Zoe Waibler
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases